{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:16:36Z","timestamp":1789665396616,"version":"4.0.1"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Primary urinary bladder marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT) is an extremely rare disease. Here, we have reported a case of MALT lymphoma that was successfully treated with transurethral resection of the bladder tumor (TUR-BT) and radiotherapy. A 65-year-old woman presented with macroscopic hematuria. She had a history of chronic cystitis. Cystoscopy of the bladder revealed a submucosal tumor measuring 4 cm in the trigone of the bladder floor. Magnetic resonance imaging showed that the lesion had intermediate intensity on T2-weighted images. TUR-BT was performed, and the lesion was diagnosed with marginal zone B-cell lymphoma of MALT histopathologically. Positron emission tomography (PET) showed a slightly higher fluorine-18-deoxyglucose (FDG) accumulation, with a maximum standardized uptake value of 17.3, than the physiological accumulation in the tumor resection area of the bladder, with no obvious abnormal accumulation outside the bladder. The patient underwent field radiotherapy at a dose of 30 Gy in 15 fractions, administered in 5 fractions per week. She developed grade 2 cystitis as an acute radiation-related adverse event, without any hematological adverse events. On PET at 5 months after radiotherapy, FDG accumulation in the posterior wall of the bladder was obscured and remained regressed after 2 years.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_238_21","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T06:51:02Z","timestamp":1657867862000},"page":"1814-1816","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Primary urinary bladder marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue"],"prefix":"10.4103","volume":"18","author":[{"given":"Atsuto","family":"Katano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideomi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-59-20241021","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.3390\/cancers13081803","article-title":"Treatments and outcomes in Stage I extranodal marginal zone lymphoma in the United States","volume":"13","author":"Alderuccio","year":"2021","journal-title":"Cancers (Basel"},{"key":"R2-59-20241021","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000502204","article-title":"Mucosa-associated lymphoid tissue lymphoma of the thyroid gland: A systematic review of the literature","volume":"9","author":"Karvounis","year":"2020","journal-title":"Eur Thyroid J"},{"key":"R3-59-20241021","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.21037\/tau-21-602","article-title":"Bladder mucosa-associated lymphoid tissue lymphoma progressed from chronic cystitis along with a comparative genetic analysis during long-term follow-up: A case report","volume":"10","author":"Ishibashi","year":"2021","journal-title":"Transl Androl Urol"},{"key":"R4-59-20241021","doi-asserted-by":"crossref","first-page":"102656","DOI":"10.1155\/2015\/102656","article-title":"Molecular pathogenesis of MALT lymphoma","volume":"2015","author":"Troppan","year":"2015","journal-title":"Gastroenterol Res Pract"},{"key":"R5-59-20241021","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1182\/blood.V98.4.1182","article-title":"T (11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10","volume":"98","author":"Liu","year":"2001","journal-title":"Blood"},{"key":"R6-59-20241021","first-page":"49","article-title":"MALT lymphoma of the urinary bladder shows a dramatic female predominance, uneven geographic distribution, and possible infectious etiology","volume":"13","author":"Lyapichev","year":"2021","journal-title":"Res Rep Urol"},{"key":"R7-59-20241021","doi-asserted-by":"crossref","first-page":"332","DOI":"10.5858\/2001-125-0332-PLGBCL","article-title":"Primary low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type arising in the urinary bladder: Report of 4 cases with molecular genetic analysis","volume":"125","author":"Al-Maghrabi","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"R8-59-20241021","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1016\/S1470-2045(20)30595-7","article-title":"Communication and ethical considerations for fertility preservation for patients with childhood, adolescent, and young adult cancer: Recommendations from the PanCareLIFE consortium and the international late effects of childhood cancer guideline harmonization group","volume":"22","author":"Mulder","year":"2021","journal-title":"Lancet Oncol"},{"key":"R9-59-20241021","doi-asserted-by":"crossref","first-page":"bcr2013202994","DOI":"10.1136\/bcr-2013-202994","article-title":"A rare urinary bladder tumour","volume":"2014","author":"Haddad-Lacle","year":"2014","journal-title":"BMJ Case Rep"},{"key":"R10-59-20241021","doi-asserted-by":"crossref","first-page":"e304","DOI":"10.1200\/JCO.2012.46.4800","article-title":"Antibiotic therapy-induced remission of bladder mucosa-associated lymphoid tissue (MALT) lymphoma carrying t(11;18)(q21;q21) apoptosis inhibitor 2-MALT1","volume":"31","author":"Lucioni","year":"2013","journal-title":"J Clin Oncol"},{"key":"R11-59-20241021","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1200\/JCO.1997.15.4.1624","article-title":"Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: Analysis of 108 patients","volume":"15","author":"Thieblemont","year":"1997","journal-title":"J Clin Oncol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_238_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:40:26Z","timestamp":1787067626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_238_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_238_21","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}